文献速递乳腺MR

乳腺癌新辅助化疗与手术:与局部复发相关的术前MRI特征

Neoadjuvant Chemotherapy and Surgery for Breast Cancer: Preoperative MRI Features Associated with Local Recurrence.
PubMed 文献 · Radiology · 2018-07-24

本回顾性单中心研究纳入2003年10月至2015年9月间548例接受新辅助化疗后保乳手术的乳腺癌患者,分析术前MRI及临床病理特征与局部区域复发的关系。中位随访23.1个月,23例(4.2%)出现局部区域复发;年龄≤40岁或术前MRI显示非肿块强化与较差的局部区域无复发生存相关。降期保乳组复发多位于原肿瘤同一象限。

要点

  • 术前MRI显示非肿块强化者局部区域复发风险较高(HR=3.220)。
  • 年龄≤40岁与较差的局部区域无复发生存相关(HR=2.932)。
  • 降期保乳组复发多位于原肿瘤同一象限(80.0% vs 33.3%)。

核心结论

  • 年龄≤40岁或术前MRI存在非肿块强化似乎与较差的局部区域无复发生存相关,且新辅助化疗后保乳手术患者的局部区域复发常位于原肿瘤同一象限。

研究设计与样本

  • 回顾性单中心研究,2003年10月至2015年9月连续纳入548例女性(降期保乳468例、计划保乳80例,平均年龄45.7岁,范围22-75岁),均接受术前MRI及新辅助化疗后保乳手术,采用Cox比例风险模型分析。

关键影像表现/征象

  • 术前MRI非肿块强化与较差的局部区域无复发生存相关(HR=3.220;95%CI:1.274,8.140;P=0.014)。
  • 降期保乳组局部区域复发位于原肿瘤同一象限的比例高于计划保乳组(80.0%[16/20] vs 33.3%[1/3];P=0.021)。

诊断标准与关键数值

  • 年龄≤40岁与较差的局部区域无复发生存相关(HR=2.932;95%CI:1.233,6.969;P=0.015)。
  • 中位随访23.1个月,548例中23例(4.2%)出现局部区域复发。

临床应用与阅片要点

  • 术前MRI评估需关注非肿块强化,并将其纳入复发风险评估。
  • 对年龄≤40岁患者,阅片时应结合MRI特征提示复发风险。
  • 降期保乳患者复发多位于原肿瘤同一象限,报告时可提示原瘤床区域重点观察。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To investigate the MRI and clinical-pathologic features associated with local-regional recurrence (LRR) in patients who had undergone breast-conserving surgery (BCS) following neoadjuvant chemotherapy (NAC). Materials and Methods In this retrospective, single-institution study between October 2003 and September 2015, 548 consecutive women, consisting of 468 down-staged and 80 preplanned BCS patients (mean age, 45.7 years; range, 22-75 years), underwent preoperative MRI and BCS following NAC. The rate and site of LRR, preoperative MRI features including Breast Imaging Reporting and Data System lexicon, and clinical-pathologic features (age, stage, tumor subtype, histologic grade, lymphovascular invasion, adjuvant chemotherapy, and endocrine therapy) were analyzed with the Cox proportional hazards model to identify independent factors associated with LRR-free survival (LRFS). Results Of the 548 women, 23 (4.2%) had LRR at a median follow-up of 23.1 months. In Cox regression analysis, younger age (ie, ≤ 40 years) (hazard ratio = 2.932; 95% confidence interval [CI]: 1.233, 6.969; P = .015) or the presence of nonmass enhancement on preoperative MR images (hazard ratio = 3.220; 95% CI: 1.274, 8.140; P = .014) was associated with worse LRFS. LRR was more frequently observed in the same quadrant as the original tumor in the down-staged BCS group than in the preplanned BCS group (80.0% [16 of 20] vs 33.3% [one of three]; P = .021). Conclusion Age of 40 years or younger or the presence of nonmass enhancement on preoperative MR images tends to be associated with worse local-regional recurrence-free survival, and local-regional recurrence frequently occurs in the same quadrant as the original tumor in breast cancer patients who undergo breast-conserving surgery following neoadjuvant chemotherapy. © RSNA, 2018.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Shin SU, Cho N, Lee HB, et al. Neoadjuvant Chemotherapy and Surgery for Breast Cancer: Preoperative MRI Features Associated with Local Recurrence. Radiology. 2018. PMID: 30040058. doi:10.1148/radiol.2018172888

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。